Shockwave’s novel Javelin intravascular lithotripsy catheter focuses acoustic energy forward to clear a path through calcium-clogged blood vessels. Johnson & Johnson MedTech’s Shockwave Medical aims to deliver intravascular lithotripsy (IVL) to … [Read More...] about How Shockwave’s Javelin IVL catheter breaks up blood-blocking calcium where balloons can’t reach
Main Content
Featured
Today on Medical Tubing & Extrusion
- How Shockwave’s Javelin IVL catheter breaks up blood-blocking calcium where balloons can’t reach
- Medtronic recalls embolization device after reported deaths
- Perfuze wins FDA nod for access catheter, raises $24M
- NanoVibronix announces reverse stock split
- Second Heart Assist says Whisper device caused less hemolysis compared to Abiomed Impella CP
Medical Tubing & Extrusion

How Shockwave’s Javelin IVL catheter breaks up blood-blocking calcium where balloons can’t reach
Shockwave’s novel Javelin intravascular lithotripsy catheter focuses acoustic energy forward to clear a path through calcium-clogged blood vessels. Johnson & Johnson MedTech’s Shockwave Medical aims to deliver intravascular lithotripsy (IVL) to … [Read More...] about How Shockwave’s Javelin IVL catheter breaks up blood-blocking calcium where balloons can’t reach

Medtronic recalls embolization device after reported deaths
By Sean Whooley
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the device. The recall involves removing Pipeline Vantage 027 device models from use and sale and updating instructions for … [Read More...] about Medtronic recalls embolization device after reported deaths

Perfuze wins FDA nod for access catheter, raises $24M
By Sean Whooley
Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding. The Galway, Ireland–based medtech company picked up about $24 million (€22 million) in a follow-on funding round. … [Read More...] about Perfuze wins FDA nod for access catheter, raises $24M

NanoVibronix announces reverse stock split
By Sean Whooley
NanoVibronix (Nasdaq:NAOV) announced today that it intends to effect a reverse stock split of its common stock. The split comes at a ratio of one post-split share for every 11 pre-split shares. Tyler, Texas-based NanoVibronix expects the split to … [Read More...] about NanoVibronix announces reverse stock split

Second Heart Assist says Whisper device caused less hemolysis compared to Abiomed Impella CP
By Sean Whooley
Second Heart Assist today announced data from a study highlighting the performance of its Whisper device against a competitive heart pump. The study showed that Whisper — a next-generation percutaneous mechanical circulatory support (pMCS) system … [Read More...] about Second Heart Assist says Whisper device caused less hemolysis compared to Abiomed Impella CP

Medtronic says new study backs Prevail paclitaxel-coated balloon
By Sean Whooley
Medtronic (NYSE: MDT) announced results from a registry highlighting the effectiveness of the Prevail drug-coated balloon (DCB). Dr. Sacharias von Koch of the Deptartment of Cardiology and Clinical Sciences at Lund University, Skåne University … [Read More...] about Medtronic says new study backs Prevail paclitaxel-coated balloon

Lungpacer wins FDA IDE for AeroNova system
By Sean Whooley
Lungpacer Medical announced today that it received FDA investigational device exemption (IDE) to begin a trial for its AeroNova system. The STARI (stimulation to activate respiration) trial evaluates the feasibility of the investigational AeroNova … [Read More...] about Lungpacer wins FDA IDE for AeroNova system